Advanced Pharmaceutical Bulletin (Feb 2013)

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells

  • Javid Shahbazi,
  • Vala Kafil,
  • Mohammad Reza Rashidi,
  • Hadi Valizadeh,
  • Davoud Asgari,
  • Jaleh Barar,
  • Mostafa Heidari Majd,
  • Yadollah Omidi

DOI
https://doi.org/10.5681/apb.2013.031
Journal volume & issue
Vol. 3, no. 1
pp. 189 – 195

Abstract

Read online

Purpose: To achieve simultaneous imaging and therapy potentials, targeted fluoromagnetic nanoparticles were synthesized and examined in human breast cancer MCF-7 cells. Methods: Fe3O4 nanoparticles (NPs) were synthesized through thermal decomposition of Fe(acac)3. Then, magnetic nanoparticles (MNPs) modified by dopamine-poly ethylene glycol (PEG)-NH2; finally, half equivalent fluorescein isothiocyanate (FITC) and half equivalent folic acid were conjugated to one equivalent of it. The presence of Fe3O4-DPA-PEG-FA/FITC in the folate receptor (FR) positive MCF-7 cells was determined via fluorescent microscopy to monitor the cellular interaction of MNPs. Results: FT-IR spectra of final compound confirmed existence of fluorescein on folic acid grafted MNPs. The Fe3O4-DPA-PEG-FA/FITC NPs, which displayed a size rang about 30-35 nm using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), were able to actively recognize the FR-positive MCF-7 cells, but not the FR-negative A549 cells. Conclusion: The uniform nano-sized Fe3O4-DPA-PEG-FA/FITC NPs displayed great potential as theranostics and can be used for targeted imaging of various tumors that overexpress FR.

Keywords